Factors Associated With Recurrence After Surgical Resection in Women With Intravenous Leiomyomatosis

医学 外科 置信区间 下腔静脉 回顾性队列研究 阶段(地层学) 子宫 静脉 内科学 生物 古生物学
作者
Xin Yu,Guorui Zhang,Jinghe Lang,Bao Liu,Dachun Zhao
出处
期刊:Obstetrics & Gynecology [Lippincott Williams & Wilkins]
卷期号:128 (5): 1018-1024 被引量:36
标识
DOI:10.1097/aog.0000000000001718
摘要

To analyze the recurrence features and prognostic factors of patients with intravenous leiomyomatosis after complete tumor resection.We conducted a retrospective study of 58 patients with intravenous leiomyomatosis with follow-up data out of 75 patients treated from September 2005 to September 2015 and an analysis of postoperative recurrence features and prognostic factors.The average patient age was 45.4 years. The preoperative diagnosis rate was low. Among the 58 total patients, 31 had tumors that spread to the inferior vena cava and heart. During the median follow-up of 11.5 months, recurrence occurred in 18 patients at a rate of 31.0% (95% confidence interval 19.0-43.0%). Recurrence was associated with the preoperative tumor extent, and large vein involvement (16/31 compared with 2/27, P=.02) was a risk factor for postoperative recurrence. Postoperative recurrence was not associated with age (1/10 in 50 years or older compared with 17/48 younger than 50 years, P=.35), involvement of the heart (10/22 compared with 8/36, P=.28), resection of the uterus (16/51 compared with 2/7, P=.84) or bilateral ovaries (15/40 compared with 3/18, P=.65) with complete tumor removal, the choice of one-stage or two-stage surgery (11/45 for one-stage surgery compared with 7/13 for two-stage surgery, P=.20), postoperative antiestrogen hormone therapy (10/24 compared with 8/34, P=.53), or the hormone therapy duration (5/17 in the over-6-months group compared with 13/41 in the under-6-months group, P=.81).The postoperative recurrence rate of intravenous leiomyomatosis was high, and large vein involvement was associated with an increased risk of recurrence. Continued postoperative follow-up is important. Neither resection of bilateral ovaries nor postoperative hormone therapy was associated with recurrence.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
jhhh发布了新的文献求助10
刚刚
顺利完成签到,获得积分10
3秒前
利乐发布了新的文献求助30
5秒前
9秒前
9秒前
11秒前
阿飞完成签到,获得积分10
12秒前
12秒前
研友_VZG7GZ应助王者归来采纳,获得10
12秒前
烟花应助小研究牲采纳,获得10
14秒前
在下风爵发布了新的文献求助10
15秒前
16秒前
17秒前
蔡雯完成签到,获得积分10
18秒前
无情向梦发布了新的文献求助10
18秒前
灵巧觅山发布了新的文献求助10
18秒前
19秒前
20秒前
Mars_1108发布了新的文献求助10
21秒前
21秒前
24秒前
房谷槐发布了新的文献求助10
24秒前
汉堡包应助阿星采纳,获得30
25秒前
cw1231完成签到 ,获得积分10
25秒前
ztayx完成签到 ,获得积分10
26秒前
严冰蝶完成签到 ,获得积分10
26秒前
小研究牲发布了新的文献求助10
26秒前
27秒前
xiaowang完成签到,获得积分10
27秒前
汉堡包应助利乐采纳,获得10
28秒前
灵巧觅山完成签到,获得积分10
31秒前
上官若男应助Lemon采纳,获得10
34秒前
李爱国应助房谷槐采纳,获得10
34秒前
37秒前
42秒前
Owen应助丛玉林采纳,获得10
42秒前
真实的德天完成签到 ,获得积分10
43秒前
44秒前
MYW完成签到,获得积分10
44秒前
馥郁完成签到,获得积分10
45秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
ISCN 2024 – An International System for Human Cytogenomic Nomenclature (2024) 3000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
T/CAB 0344-2024 重组人源化胶原蛋白内毒素去除方法 1000
Maneuvering of a Damaged Navy Combatant 650
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3775612
求助须知:如何正确求助?哪些是违规求助? 3321229
关于积分的说明 10204285
捐赠科研通 3036074
什么是DOI,文献DOI怎么找? 1665997
邀请新用户注册赠送积分活动 797213
科研通“疑难数据库(出版商)”最低求助积分说明 757766